Microbira at the 33rd ECCMID Copenhagen, presenting rapid microorganism identification, Denmark 15-18 April 2023 annual conference
Marianne Ismail, CEO of Microbira, opened the Diagnostics Pipeline Corner at ECCMID in Denmark. This popular session allows small and medium-sized enterprises worldwide to showcase research and products. During her presentation, Marianne highlighted the latest version of the Microbira Advanced Analytical Platform – Infrared (MAAP-IR). She also shared results from ongoing collaborations with NHS North East Innovation Lab and other laboratories.
Introducing MAAP-IR
The UKCA designates MAAP-IR as a software medical device for the rapid identification of microorganisms. Moreover, the software analyses spectra collected from an attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectrometer. Afterward, the system delivers results within minutes of the initial culture. This ensures swift and accurate diagnostic outcomes.
Additionally, MAAP-IR leverages Fourier Transform Infrared (FTIR) spectroscopy and advanced AI algorithms to identify microorganisms. Impressively, it detects over 20 clinically relevant species, including Escherichia coli, Staphylococcus aureus, and Candida auris, in just five minutes. Therefore, clinicians can quickly detect infectious microorganisms and improve the efficiency of their workflows.
Furthermore, one of MAAP-IR’s key features is its reagent-free design. This makes microbial identification not only cost-effective but also highly accessible. In addition, the system incorporates cloud-based AI technology and proprietary spectral databases. These ensure both reliability and precision in every diagnosis.
As a result, MAAP-IR delivers rapid microorganism identification while reducing delays in diagnosis and treatment. Ultimately, this efficiency supports clinicians in making timely and informed decisions that improve patient outcomes.
Showcasing Innovation
The 33rd ECCMID provided Microbira with a valuable opportunity to show MAAP-IR’s capabilities to a global audience. Marianne Ismail’s presentation highlighted how this cutting-edge technology addresses the growing need for accessible, rapid diagnostic tools. By attending ECCMID, Microbira reinforced its commitment to innovation and its role as a leader in diagnostic solutions.
Microbira’s participation at ECCMID underscores the company’s dedication to improving healthcare through advanced diagnostics. As the fight against antimicrobial resistance and infectious diseases continues, tools like MAAP-IR will play a critical role in shaping the future of healthcare.
Visit our product page for more information on MAAP-IR.
